Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Abstract Text:

    ales linhartAles Linhart,christoph kampmannChristoph Kampmann, zamorano Zamorano,gere sunder-plassmannGere Sunder-Plassmann,michael beckMichael Beck,atul mehtaAtul Mehta,perry m elliottPerry M Elliott, ,ales linhartAles Linhart,christoph kampmannChristoph Kampmann, zamorano Zamorano,gere sunder-plassmannGere Sunder-Plassmann,michael beckMichael Beck,atul mehtaAtul Mehta,perry m elliottPerry M Elliott, ,

    AIMS: Anderson-Fabry disease (AFD) is an uncommon X-linked disorder caused by deficient activity of the lysosomal enzyme alpha-galactosidase A. The Fabry Outcome Survey is a European database designed to monitor the long-term efficacy and safety of enzyme replacement therapy (ERT) with agalsidase alfa. The aim of this study was to determine the prevalence and characteristics of cardiac disease in AFD patients. METHODS AND RESULTS: Clinical and laboratory data were available in 714 patients from 11 countries (mean age 35 +/- 17 years, 369 women, 336 treated). The prevalence of angina was 23 vs. 22%; palpitations and arrhythmias 27 vs. 26%; exertional dyspnoea 23 vs. 23%; and syncope 2 vs. 4%, in women and men, respectively (all P = NS). The frequency of all cardiac symptoms was significantly higher in treated than in untreated patients. Gender, age, and glomerular filtration rate were independent determinants of echocardiographically assessed left ventricular hypertrophy (LVH). CONCLUSION: This study confirms the high prevalence of cardiac morbidity associated with AFD. The disease burden in treated women exceeds that of untreated men, suggesting that most women selected for ERT have advanced disease. The presence of LVH is associated with higher frequency of cardiac signs and symptoms and relates independently to gender, age, and renal function.

    Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Publishing Authors By Initials

    a linhartA Linhart,c kampmannC Kampmann,jl zamoranoJL Zamorano,g sunder-plassmannG Sunder-Plassmann,m beckM Beck,a mehtaA Mehta,pm elliottPM Elliott, ,a linhartA Linhart,c kampmannC Kampmann,jl zamoranoJL Zamorano,g sunder-plassmannG Sunder-Plassmann,m beckM Beck,a mehtaA Mehta,pm elliottPM Elliott, ,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: European heart journal

    VOLUME: 28

    Page Numbers: 1228-35

    Journal Abbreviation: Eur. Heart J.

    ISSN: 0195-668X

    DAY: 5

    MONTH: 05

    YEAR: 2007

    Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8006263

    Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

    AFFILIATION: Second Department of Internal Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic. alinh@lf1.cuni.cz

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Eur Heart J

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News